MARIA BIARD, MD

Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use

Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit

Testing of autonomic (sympathetic) nervous system function

Complete ultrasound study of arm and leg arteries

New patient office or other outpatient visit, 45-59 minutes

Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Ultrasound study of arm and leg arteries

Evaluation of psychological test, first hour

Established patient office or other outpatient visit, 30-39 minutes

Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza

Test for balance and posture

Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month

Established patient office or other outpatient visit, 20-29 minutes

Photography of the retina

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Dxa bone density measurement of hip, pelvis, spine

Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days

Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a

Management using the results of remote vital sign monitoring per calendar month, first 20 minutes

Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes

Test to measure expiratory airflow and volume

Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes

Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage

Administration of pneumococcal vaccine

X-ray of chest, 2 views

Administration of influenza virus vaccine

Administration of vaccine

X-ray of shoulder, minimum of 2 views

Injection of drug or substance under skin or into muscle

Annual alcohol misuse screening, 5 to 15 minutes

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Annual depression screening, 5 to 15 minutes

Hemoglobin a1c level

Injection, methylprednisolone acetate, 40 mg

Urine microalbumin (protein) analysis

Creatinine level to test for kidney function or muscle injury

Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Injection, ketorolac tromethamine, per 15 mg

Automated urinalysis test

Injection, dexamethasone sodium phosphate, 1 mg

Administration and interpretation of patient-focused health risk assessment

Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional